Discover trends, market shifts, and competitive outlooks for the antibody discovery industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Antibody Discovery Market Size from 2025 to 2034?

The size of the antibody discovery market has seen significant expansion recently. It is projected to increase from $8.96 billion in 2024 to $9.87 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.2%. The historical period’s growth can be tied to a boost in drug discovery investments, an escalation in research and development activities, and the existence of numerous healthcare research institutions and academic centres.

The market for antibody discovery is forecasted to experience significant expansion in the coming years, projected to reach $14.6 billion by 2029. This growth represents a compound annual growth rate (CAGR) of 10.3%. The surge expected within the forecast period is attributable to many factors, such as the heightened requirement for antibody drug discovery services and platforms. Moreover, an increase in funding aimed at the inception of innovative technologies, a growing need for precision therapeutics, and a broadened use of antibodies outside of their traditional therapeutic roles also contribute. Key trends within this forecasted period include a rise in research and development initiatives, an increased demand for monoclonal antibodies, greater use of sophisticated technologies, elevated need for targeted therapeutics, and the invention of cutting-edge antibody formats.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Antibody Discovery Market?

The antibody discovery market’s expansion is expected to be fueled by an increasing demand for precision therapeutics, which aims at personalizing medical treatments based on individual patient attributes. Antibody discovery contributes significantly to this shift towards personalized treatments by enabling targeted therapies like monoclonal antibodies. These therapies are scientifically crafted to specifically and accurately interact with disease-related molecules or cells, leading to more effective personalized care. Evidence of this growth was reflected in January 2023, when, as per the Personalized Medicine Coalition, a professional membership organization in the U.S, the Center for Drug Evaluation and Research (CDER) under the Food and Drug Administration approved 37 new molecular entities (NMEs) in 2022. From these, around 34% or 12 of the 35 therapeutic NMEs were categorized as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the escalating demand for precision therapeutics is set to further propel the growth of the antibody discovery market.

Which Primary Segments of the Antibody Discovery Market Are Driving Growth and Industry Transformations?

The antibody discovery market covered in this report is segmented –

1) By Methods: Phage Display, Hybridoma, Other Methods

2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:

1) By Phage Display: Selection And Screening Techniques, Optimization Methods

2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

Which Regions Are Key Players in the Growth of the Antibody Discovery Market?

North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Antibody Discovery Market?

Leading firms in the antibody discovery market are advancing unique technologies, such as AI-integrated computational antibody drug discovery platforms, to enhance the effectiveness and accuracy of antibody development. These platforms leverage artificial intelligence and computational methods to speed up the identification and improvement of therapeutic antibodies. For instance, SwiftPharma BV, a company from Belgium that develops recombinant proteins from a dedicated plant-based system, launched an AI-powered antibody discovery platform in October 2023. This cutting-edge tool merges artificial intelligence, big data analytics, machine learning, and phage display techniques to quickly forecast antibody-antigen binding with high specificity and high affinity. The method, similar to natural language processing tactics, develops a diverse array of antibody variations, which enable SwiftPharma to generate exhaustive antibody libraries with great efficiency. This modern system prompts the discovery of potential antibody drugs at an unprecedented rate.

View the full report here:

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

What Parameters Are Used to Define the Antibody Discovery Market?

Antibody discovery refers to the process of identifying and developing antibodies, which are proteins produced by the immune system to help defend the body against harmful substances, such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a crucial role in the immune response by recognizing and binding to specific molecules called antigens.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model